Raise closed, search for fresh raises on Seedstage

Cheyenne, WY

Launching in-home pet health testing kits to enhance convenience and care.

• Innovative technology: Exclusive use of patented dry blood collection card for in-home pet testing.
• Cost and time efficiency: Reduces the need for vet visits and provides results in 3-5 days.
• Stress-free solution: Minimizes pet stress through non-invasive, at-home sampling.
• First-mover advantage: Pioneering in-home blood sample collection for pets with comprehensive health panels.
• Growing market demand: Positioned to address the expanding pet healthcare industry driven by increased spending and awareness.

CheckMyPet XP is transforming pet healthcare by pioneering in-home blood testing solutions, addressing common challenges in traditional veterinary care such as high costs, time constraints, and pet stress. Using patented dry blood collection card technology, the platform enables pet owners to collect small blood samples easily at home, ensuring accurate, comprehensive, and reliable results without the need for invasive procedures or cold storage. This innovation provides early detection capabilities for hidden health issues, empowering pet owners to take proactive measures for their pets’ well-being.

The company seeks to utilize the funds raised to validate key health test panels, secure initial inventory, and support operational costs as it prepares for larger funding rounds in the future. CheckMyPet XP aims to redefine pet diagnostics by offering a cost-effective, stress-free alternative to traditional testing methods, while fostering a stronger connection between pets and their owners. Through its innovative approach and exclusive technology, CheckMyPet XP is poised to fill a critical gap in the rapidly growing pet healthcare market.

Company Info

CheckMyPet XP offers innovative at-home pet health testing kits using patented dry blood collection technology, allowing early detection of health issues.

CheckMyPet XP (CMP) is revolutionizing the pet healthcare industry by offering at-home blood sample collection kits for pets. The platform uses patented dry blood collection technology that enables pet owners to detect potential health issues early, from the comfort of their own home. CMP’s innovative approach allows for easier, more accurate testing, and is a non-invasive alternative to traditional veterinary visits. Unlike traditional methods, the CMP kits do not require cold storage or large, painful needles. The process involves using a small gauge needle to collect a blood sample and send it to the lab for analysis, providing results in 3-5 days.

The company’s mission is to make pet healthcare more affordable, accessible, and less stressful for both pets and their owners. CMP addresses several challenges in the pet healthcare market, including high costs, inconvenience, and the anxiety caused by vet visits. With its patented dry blood collection card, CMP has exclusive rights in the pet healthcare space and aims to empower pet owners to take a proactive role in their pets’ health. This technology not only reduces stress for pets but also allows for comprehensive health monitoring with a wide range of testing panels, all done at home.